Keybank National Association OH lessened its stake in shares of The Sherwin-Williams Company (NYSE:SHW - Free Report) by 1.1% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 321,027 shares of the specialty chemicals company's stock after selling 3,545 shares during the quarter. Keybank National Association OH owned about 0.13% of Sherwin-Williams worth $109,127,000 as of its most recent SEC filing.
Several other hedge funds have also recently made changes to their positions in SHW. Farther Finance Advisors LLC lifted its holdings in shares of Sherwin-Williams by 2.8% during the 3rd quarter. Farther Finance Advisors LLC now owns 3,469 shares of the specialty chemicals company's stock valued at $1,324,000 after buying an additional 96 shares during the period. Chicago Partners Investment Group LLC increased its position in Sherwin-Williams by 8.5% during the third quarter. Chicago Partners Investment Group LLC now owns 1,841 shares of the specialty chemicals company's stock valued at $668,000 after acquiring an additional 144 shares during the last quarter. Princeton Global Asset Management LLC bought a new position in Sherwin-Williams in the third quarter valued at about $61,000. Conning Inc. boosted its position in Sherwin-Williams by 50.1% in the third quarter. Conning Inc. now owns 2,411 shares of the specialty chemicals company's stock worth $920,000 after purchasing an additional 805 shares during the last quarter. Finally, Van ECK Associates Corp grew its stake in shares of Sherwin-Williams by 8.8% during the 3rd quarter. Van ECK Associates Corp now owns 50,946 shares of the specialty chemicals company's stock valued at $18,479,000 after purchasing an additional 4,132 shares during the period. 77.67% of the stock is owned by hedge funds and other institutional investors.
Sherwin-Williams Price Performance
Shares of NYSE:SHW traded up $7.26 during midday trading on Wednesday, reaching $362.54. 1,985,635 shares of the company were exchanged, compared to its average volume of 1,597,785. The company has a current ratio of 0.79, a quick ratio of 0.46 and a debt-to-equity ratio of 2.02. The stock has a market cap of $91.18 billion, a PE ratio of 34.36, a price-to-earnings-growth ratio of 2.98 and a beta of 1.22. The business's fifty day moving average is $351.67 and its two-hundred day moving average is $365.87. The Sherwin-Williams Company has a one year low of $282.09 and a one year high of $400.42.
Sherwin-Williams (NYSE:SHW - Get Free Report) last released its quarterly earnings data on Thursday, January 30th. The specialty chemicals company reported $2.09 EPS for the quarter, beating the consensus estimate of $2.07 by $0.02. Sherwin-Williams had a net margin of 11.61% and a return on equity of 74.50%. During the same quarter in the prior year, the firm posted $1.81 earnings per share. As a group, analysts predict that The Sherwin-Williams Company will post 12 earnings per share for the current year.
Sherwin-Williams Increases Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Friday, March 14th. Stockholders of record on Monday, March 3rd will be issued a dividend of $0.79 per share. This represents a $3.16 annualized dividend and a dividend yield of 0.87%. This is a boost from Sherwin-Williams's previous quarterly dividend of $0.72. The ex-dividend date is Monday, March 3rd. Sherwin-Williams's dividend payout ratio is 29.95%.
Insider Activity
In other news, insider Colin M. Davie sold 2,799 shares of the company's stock in a transaction dated Thursday, February 27th. The shares were sold at an average price of $360.30, for a total transaction of $1,008,479.70. Following the sale, the insider now directly owns 5,365 shares in the company, valued at approximately $1,933,009.50. This represents a 34.28 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 0.60% of the company's stock.
Wall Street Analyst Weigh In
SHW has been the topic of a number of research reports. Zelman & Associates raised shares of Sherwin-Williams to a "strong-buy" rating in a report on Friday, January 17th. Royal Bank of Canada dropped their price target on shares of Sherwin-Williams from $438.00 to $415.00 and set an "outperform" rating on the stock in a research note on Monday, February 3rd. StockNews.com lowered Sherwin-Williams from a "buy" rating to a "hold" rating in a research note on Thursday, November 28th. Morgan Stanley decreased their target price on Sherwin-Williams from $450.00 to $405.00 and set an "overweight" rating on the stock in a report on Tuesday, January 28th. Finally, Evercore ISI boosted their price target on Sherwin-Williams from $400.00 to $420.00 and gave the company an "outperform" rating in a report on Thursday, November 7th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating, eleven have issued a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat, Sherwin-Williams currently has a consensus rating of "Moderate Buy" and an average price target of $403.31.
Check Out Our Latest Research Report on SHW
About Sherwin-Williams
(
Free Report)
The Sherwin-Williams Company engages in the development, manufacture, distribution, and sale of paints, coating, and related products to professional, industrial, commercial, and retail customers. It operates through three segments: Paint Stores Group, Consumer Brands Group, and Performance Coatings Group.
Featured Stories

Before you consider Sherwin-Williams, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sherwin-Williams wasn't on the list.
While Sherwin-Williams currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.